The Emmott and Eyers labs in the CPR are part of the COVID-19 Mass Spectrometry Coalition (, looking to apply MS-based methods to advance COVID-19 diagnostics, prognostic biomarkers, and treatments. Our letter on the COVID-19 MSC and it’s goals has been published in the Lancet: The COVID-19 MS Coalition—accelerating diagnostics, prognostics, and treatment . This is in addition to the labs own research on SARS-CoV-2.


The COVID-19 MSC and its efforts have been widely described in the media, including ITV news, Sky news, Al-Jazeera news24, and BBC Science Focus.

Comments are closed, but trackbacks and pingbacks are open.